Failure to Warn, Failure to Keep Safe
Good medical decisions require complete information. Unfortunately, however, some pharmaceudical manufacturers have failed to appropriately or completely warn consumers and potential consumers about the risks of their product. Specifically, the makers of popular antidepressants known as selective serotonin reuptake inhibitors (SSRIs) have faltered in their dedication to fully advise pregnant patients.
Recent U.S. Food and Drug Administration (FDA) research has found that some children of SSRI patients suffered birth defects as a result of their pregnant mother’s antidepressant drug. Adverse events including cardiac, pulmonary, and behavioral conditions have impacted their development and, in some cases, permanently hindered their normal growth.
Does this sound familiar to you? If your family member has suffered as a result of prenatal SSRI exposure it may be time to speak with the attorneys and dedicated professionals at Fears Nachwati. With years of experience, we know how to defend you. For your free consultation, call us at 1.866.545.8364 or email email@example.com.